Richard M. Wright sold Celldex Therapeutics ($CLDX) shares once on the open market in the last year, totaling $1.2 million, with his most recent sale on November 13, 2025. His sales rank 4,548th among 11,678 individual insiders, below the average of $8.6 million per seller and 6.37 transactions. He made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 13, 2025 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | Not found | M | Incentive Stock Option | 15750 | $0.00 | 7,875.0000 | 66,420 | 66.67% | 23.71% |
| Nov. 13, 2025 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | Not found | M | Common Stock | 6876 | $9.02 | 27,709.0000 | 66,420 | 33.01% | 10.35% |
| Nov. 13, 2025 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | Not found | M | Common Stock | 26672 | $10.38 | 54,381.0000 | 66,420 | 96.26% | 40.16% |
| Nov. 13, 2025 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | Not found | M | Common Stock | 15750 | $22.48 | 70,131.0000 | 66,420 | 28.96% | 23.71% |
| Nov. 13, 2025 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | Not found | S | Common Stock | 49298 | $24.00 | 20,833.0000 | 66,420 | 70.29% | 74.22% |
| Nov. 13, 2025 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | Not found | M | Incentive Stock Option | 6876 | $0.00 | 0.0000 | 66,420 | 100.00% | 10.35% |
| Nov. 13, 2025 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | Not found | M | Incentive Stock Option | 26672 | $0.00 | 0.0000 | 66,420 | 100.00% | 40.16% |
| June 13, 2024 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | SR. VP & CCO | A | Incentive Stock Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 58,871 | 9999.99% | 100.00% |
| June 3, 2024 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | SR. VP & CCO | M | Incentive Stock Option (right to buy) | 18375 | $0.00 | 23,625.0000 | 58,871 | 43.75% | 31.21% |
| June 3, 2024 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | SR. VP & CCO | M | Common Stock | 20625 | $2.78 | 20,833.0000 | 58,871 | 9915.87% | 35.03% |
| June 3, 2024 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | SR. VP & CCO | M | Common Stock | 28469 | $28.00 | 49,302.0000 | 58,871 | 136.65% | 48.36% |
| June 3, 2024 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | SR. VP & CCO | M | Common Stock | 18375 | $22.48 | 67,677.0000 | 58,871 | 37.27% | 31.21% |
| June 3, 2024 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | SR. VP & CCO | S | Common Stock | 27580 | $33.53 | 40,097.0000 | 58,871 | 40.75% | 46.85% |
| June 3, 2024 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | SR. VP & CCO | S | Common Stock | 19264 | $33.99 | 20,833.0000 | 58,871 | 48.04% | 32.72% |
| June 3, 2024 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | SR. VP & CCO | M | Incentive Stock Option (right to buy) | 20625 | $0.00 | 0.0000 | 58,871 | 100.00% | 35.03% |
| June 3, 2024 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | SR. VP & CCO | M | Incentive Stock Option (right to buy) | 28469 | $0.00 | 13,531.0000 | 58,871 | 67.78% | 48.36% |
| June 15, 2023 | Celldex Therapeutics, Inc. | $CLDX | Wright Richard M. | SR. VP & CCO | A | Incentive Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 47,214 | 9999.99% | 95.31% |